Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.240
+0.020 (0.90%)
At close: Feb 21, 2025, 4:00 PM
2.230
-0.010 (-0.45%)
After-hours: Feb 21, 2025, 7:49 PM EST
Inovio Pharmaceuticals Market Cap
Inovio Pharmaceuticals has a market cap or net worth of $80.86 million as of February 21, 2025. Its market cap has decreased by -32.95% in one year.
Market Cap
80.86M
Enterprise Value
8.50M
1-Year Change
-32.95%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since March 31, 1999, Inovio Pharmaceuticals's market cap has increased from $71.80M to $80.86M, an increase of 12.62%. That is a compound annual growth rate of 0.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 58.50M | 22.38% |
Dec 31, 2024 | 47.80M | -65.66% |
Dec 29, 2023 | 139.20M | -64.23% |
Dec 30, 2022 | 389.20M | -62.93% |
Dec 31, 2021 | 1.05B | -29.98% |
Dec 31, 2020 | 1.50B | 354.33% |
Dec 31, 2019 | 330.00M | -13.48% |
Dec 31, 2018 | 381.40M | 2.28% |
Dec 29, 2017 | 372.90M | -27.45% |
Dec 30, 2016 | 514.00M | 5.96% |
Dec 31, 2015 | 485.10M | -12.78% |
Dec 31, 2014 | 556.20M | -7.96% |
Dec 31, 2013 | 604.30M | 768.25% |
Dec 31, 2012 | 69.60M | 27.71% |
Dec 30, 2011 | 54.50M | -54.51% |
Dec 31, 2010 | 119.80M | 2.92% |
Dec 31, 2009 | 116.40M | 408.30% |
Dec 31, 2008 | 22.90M | -43.18% |
Dec 31, 2007 | 40.30M | -65.53% |
Dec 29, 2006 | 116.90M | 163.88% |
Dec 30, 2005 | 44.30M | -38.64% |
Dec 31, 2004 | 72.20M | -1.77% |
Dec 31, 2003 | 73.50M | 440.44% |
Dec 31, 2002 | 13.60M | -37.04% |
Dec 31, 2001 | 21.60M | -15.63% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 785.37B |
UnitedHealth Group | 462.31B |
Johnson & Johnson | 378.26B |
Novo Nordisk | 365.53B |
AbbVie | 347.77B |
AstraZeneca | 230.61B |
Abbott Laboratories | 227.70B |
Intuitive Surgical | 215.59B |